Alport syndrome news

June 12, 2017

Regulus Back on Track with RG-012 Clinical Development for Alport Syndrome

Regulus Therapeutics has completed dosing of its Alport syndrome drug candidate RG-012 in a Phase 1 trial testing several ascending doses of the treatment in healthy volunteers. The treatment ... Read more

June 9, 2017June 9, 2017

Alport Syndrome Foundation’s Virtual Walk Kicks Off June 17

Alport syndrome news, News

The Alport Syndrome Foundation (ASF) welcomes all who are interested to take part in its 2nd Annual Virtual Walk, a fundraising event to help fight Alport syndrome. Virtual walk participants can walk anytime, anywhere, ... Read more